Regeneron’s Antibody Treatment Gets FDA Emergency Authorization
On Saturday the FDA granted emergency use authorization for REGN-COV2, Regeneron's therapy that is a cocktail of two monoclonal antibodies. While the drug was still experimental it was given to President Donald Trump.